CBL-backed Affidea completed an investment in b-rayZ.

CBL-backed Affidea, a pan-European provider of diagnostic imaging, polyclinic, and specialist healthcare services, completed an investment in b-rayZ, a provider of AI-powered breast imaging solutions. Financial terms were not disclosed. “Every woman’s journey through breast cancer diagnosis is unique, and our AI solutions are designed to provide the highest level of diagnostic accuracy and efficiency, tailored to each one’s needs. Being selected by Affidea as their preferred AI partner is a testament to our shared vision of transforming breast cancer diagnostics. Affidea’s investment in our Series A extension further validates this alignment and fuels our ambition to scale. Through this strategic partnership, we are combining our technological expertise with Affidea’s extensive clinical network to ensure that women across Europe receive faster, more precise, and more personalised breast imaging solutions,” Cristina Rossi, b-rayZ CEO and Founder.